UP Matrix ScorecardLast updated: June 2026
HealthPort
HealthPort has the ability to breakeven commercially, which would make their intervention financially sustainable for the long term. However, it remains to be seen whether they can onboard enough hospitals with the resources to pay their fees, and the exact effectiveness of medical oxygen varies widely. A risky grant but one that could have a large pay off.
Overall Rating
Cost Effectiveness Rating
Cost Effectiveness Rationale$141/DALYaverted
Our RecommendationCautious Buy
Key Information
Overview
HealthPort builds solar-powered plants in Nigeria, to produce medical oxygen and supply it to hospitals for use in critical care.
RegistrationNigeria
Turnover (USD)$367k
StageEarly mid-stage
Countries ActiveNigeria
54321Intervention Evidence QualityOrganisation Evidence QualityPotential for ScalePayer-at-scale InterestFit for Global Health Fund
The UP Index™2.8 / 5
Pathways to Scale
Payer-at-scale Interest
Government Adoption
Franchise/Replication (by other NGOs)
Commercial Revenue
Impact Metrics
Death prevented (per $1M at scale)192
ConfidenceLow
Cost per DALY averted$141
Total annual reachNot currently monitored
International Evidence
Intervention Evidence QualityRationale: No RCTs for ethical reasons, but total medical consensus
MediumQuasi-Experimental
Single RCT
Multiple RCTs
Meta-Analysis
Implementation Evidence
Organisation / Programme Evidence QualityRationale: Evidence of market demand but no studies of health improvements
LowPilot Study
Quasi-Experimental
Single RCT
Multiple RCTs